These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6623380)

  • 21. The pathology of scleroderma vascular disease.
    Fleming JN; Schwartz SM
    Rheum Dis Clin North Am; 2008 Feb; 34(1):41-55; vi. PubMed ID: 18329531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the lungs in progressive systemic sclerosis (scleroderma)].
    Kodolova IM; Preobrazhenskaia TM
    Arkh Patol; 1972; 34(4):59-65. PubMed ID: 5043687
    [No Abstract]   [Full Text] [Related]  

  • 23. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
    Jablonska S; Blaszczyk M
    Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?].
    Stoll T; Brühlmann P; Fontana A; Gmür J; Michel BA
    Schweiz Med Wochenschr; 1994 Feb; 124(5):193-203. PubMed ID: 8128201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment.
    Lee P; Leung FY; Alderdice C; Armstrong SK
    J Rheumatol; 1983 Dec; 10(6):930-8. PubMed ID: 6663597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
    Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
    J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases.
    Malandrini A; Selvi E; Villanova M; Berti G; Sabadini L; Salvadori C; Gambelli S; De Stefano R; Vernillo R; Marcolongo R; Guazzi G
    J Rheumatol; 2000 May; 27(5):1203-6. PubMed ID: 10813288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of histopathologic analysis of skin lesions in scleromyxedema. Light microscopy, electron microscopy, immunohistochemistry and immunofluorescence microscopy].
    Krajnc I; Vizjak A; Hvala A; Jurcic V; Rozman B
    Acta Med Austriaca; 1998; 25(3):109-12. PubMed ID: 9816405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma).
    Hietaharju A; Jääskeläinen S; Kalimo H; Hietarinta M
    Muscle Nerve; 1993 Nov; 16(11):1204-12. PubMed ID: 8413372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated vascular endothelial growth factor in systemic sclerosis.
    Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
    J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
    Rajkumar VS; Sundberg C; Abraham DJ; Rubin K; Black CM
    Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early diagnosis of progressive systemic sclerosis: the role of oro-facial phenomena].
    Scardina GA; Mazzullo M; Messina P
    Minerva Stomatol; 2002; 51(7-8):311-7. PubMed ID: 12434126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal involvement in progressive systemic sclerosis. Report of 3 cases, one with ultrastructural study.
    Parichatikanond P; Parichatikanond P; Ratanarapee S; Dharamadach A
    J Med Assoc Thai; 1983 Sep; 66(9):558-66. PubMed ID: 6655398
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of relationship between functional ability and skin score in patients with systemic sclerosis.
    Herrick A; Rooney B; Finn J; Silman A
    J Rheumatol; 2001 Feb; 28(2):292-5. PubMed ID: 11246664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vesical dysfunction in systemic sclerosis (scleroderma).
    Lazzeri M; Beneforti P; Benaim G; Corsi C; Ciambrone V; Marrapodi E; Mincione G; Turini D
    J Urol; 1995 Apr; 153(4):1184-7. PubMed ID: 7869494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Madecassol treatment of systemic and localized scleroderma].
    Guseva NG; Starovoĭtova MN; Mach ES
    Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of extracorporeal photochemotherapy on alpha1(I) and alpha1(III) procollagen mRNA expression in systemic sclerosis skin tissue.
    Ohtsuka T; Okita H; Yamakage A; Yamazaki S
    Arch Dermatol Res; 2002 Feb; 293(12):642-5. PubMed ID: 11875648
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP
    Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046
    [No Abstract]   [Full Text] [Related]  

  • 40. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.